Table 1.
Author | Trials | Probiotic | Result |
---|---|---|---|
Jian et al. [37] | 8 RCT (n = 1372) | Lactobacilli + triple therapy | Pooled eradication rate Probiotic: 82.26% (95% CI = 78.01–86.51%) No probiotic: 76.97% (95% CI = 73.11–80.83%) OR = 1.78 (95% CI = 1.21–2.62) |
Sachdeva and Nagpal [38] | 10 RCT (n = 963) | Multistrain (fermented milk) + triple or quadruple therapy | Eradication rates were improved by approximately 5–15% OR = 1.91 (95% CI: 1.38–2.67) |
Dang et al.[39] | 33 RCT (n = 4459), 9 RCT for children, 24 RCT for adults | Probiotics + triple therapy or sequential therapy or quadruple therapy | The pooled eradication rate in probiotic supplementation groups was significantly higher than that in controls (RR = 1.122, 95% CI = 1.086–1.159) |
Szajewska et al.[40] | 9 RCT (adult, n = 1708) 2 RCT (children, n = 330) |
Saccharomyces boulardii + triple therapy | Eradication rate (adult) Probiotic: 80.0% (95% CI = 77–82) No probiotic: 71.0% (95% CI = 68–74) RR = 1.11, 95% CI = 1.06–1.17 Eradication rate (children) Probiotic: 87.5% No probiotic:77.2% RR = 1.13, 95% CI = 1.03–1.25 |
Zhang et al. [41] | 45 RCT (n = 6997) | Probiotics + standard therapy | Eradication rate Probiotic: 82.31% No probiotics: 72.08% (RR: 1.11; 95% CI: 1.08–1.15) Side effects (RR = 0.59; 95% CI = 0.48–0.71) Probiotic: 21.44% No probiotic: 36.27% |
Wen et al. [42] | 17 RCT in Asian pediatric patients (n = 1932) | Multistrain probiotics + 14-day triple therapy | Bifidobacterium infantis + Clostridium butyricum was most beneficial for eradication rates (RR: 1.16, 95% CI: 1.07–1.26) |
Losurdo et al. [43] | 7 RCT (n = 517) | Probiotic strain alone | The mean weighted eradication rate was 14% (95% CI = 2%–25%) Lactobacilli: 16% (95% CI: 1%–31%) Saccharomyces boulardii: 12% (95% CI: 0%–29%) Multistrain: 14% (95% CI: 0%–43%) |